| hexose transmembrane transport | GO:0035428 | 7 | 1.000 | |
| anion transmembrane transport | GO:0098656 | 71 | 0.997 | |
| transmembrane transport | GO:0055085 | 412 | 0.976 | |
| carnitine transmembrane transport | GO:1902603 | 3 | 0.976 | |
| regulation of renal output by angiotensin | GO:0002019 | 2 | 0.971 | |
| response to osmotic stress | GO:0006970 | 21 | 0.967 | |
| amino acid transmembrane transport | GO:0003333 | 37 | 0.922 | |
| urogenital system development | GO:0001655 | 261 | 0.918 | |
| anion transport | GO:0006820 | 177 | 0.918 | |
| renin angiotensin regulation of aldosterone production | GO:0002018 | 3 | 0.912 | |
| inorganic anion transmembrane transport | GO:0098661 | 29 | 0.906 | |
| carnitine transport | GO:0015879 | 3 | 0.891 | |
| renal tubule development | GO:0061326 | 87 | 0.863 | |
| vitamin transport | GO:0051180 | 10 | 0.861 | |
| fluid transport | GO:0042044 | 14 | 0.858 | |
| carbohydrate transport | GO:0008643 | 62 | 0.846 | |
| hydrogen ion transmembrane transport | GO:1902600 | 25 | 0.840 | |
| inorganic anion transport | GO:0015698 | 43 | 0.812 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.808 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.805 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.805 | |
| regulation of activation of jak2 kinase activity | GO:0010534 | 1 | 0.793 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.790 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.778 | |
| amino acid betaine transport | GO:0015838 | 3 | 0.778 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.757 | |
| glucose transport | GO:0015758 | 56 | 0.756 | |
| positive regulation of transforming growth factor beta secretion | GO:2001203 | 1 | 0.734 | |
| renal system process | GO:0003014 | 48 | 0.733 | |
| circulatory system process | GO:0003013 | 197 | 0.731 | |
| organic anion transport | GO:0015711 | 137 | 0.729 | |
| activation of nf kappab inducing kinase activity | GO:0007250 | 4 | 0.711 | |
| activation of janus kinase activity | GO:0042976 | 2 | 0.669 | |
| water transport | GO:0006833 | 12 | 0.662 | |
| histamine uptake | GO:0051615 | 1 | 0.624 | |
| urate transport | GO:0015747 | 1 | 0.619 | |
| regulation of ph | GO:0006885 | 26 | 0.588 | |
| renal system process involved in regulation of systemic arterial blood pressure | GO:0003071 | 15 | 0.541 | |
| hexose transport | GO:0008645 | 56 | 0.533 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.505 | |
| regulation of systemic arterial blood pressure by circulatory renin angiotensin | GO:0001991 | 13 | 0.496 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.495 | |
| bicarbonate transport | GO:0015701 | 7 | 0.495 | |
| response to peptide | GO:1901652 | 136 | 0.473 | |
| regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1902238 | 1 | 0.463 | |
| regulation of systemic arterial blood pressure by hormone | GO:0001990 | 25 | 0.462 | |
| rhythmic process | GO:0048511 | 174 | 0.455 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.455 | |
| response to fructose | GO:0009750 | 2 | 0.449 | |
| monovalent inorganic cation homeostasis | GO:0055067 | 33 | 0.442 | |
| urea transmembrane transport | GO:0071918 | 2 | 0.432 | |
| steroid metabolic process | GO:0008202 | 119 | 0.431 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.426 | |
| regulation of systemic arterial blood pressure by renin angiotensin | GO:0003081 | 20 | 0.408 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.408 | |
| monosaccharide transport | GO:0015749 | 58 | 0.403 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.399 | |
| response to peptide hormone | GO:0043434 | 127 | 0.393 | |
| carbohydrate transmembrane transport | GO:0034219 | 10 | 0.385 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.383 | |
| progesterone metabolic process | GO:0042448 | 4 | 0.373 | |
| regulation of phospholipase a2 activity | GO:0032429 | 3 | 0.357 | |
| ureteric bud development | GO:0001657 | 94 | 0.344 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.337 | |
| modified amino acid transport | GO:0072337 | 5 | 0.333 | |
| sodium ion transport | GO:0006814 | 73 | 0.330 | |
| vasodilation | GO:0042311 | 28 | 0.328 | |
| intestinal absorption | GO:0050892 | 13 | 0.326 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.326 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.322 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.314 | |
| amino acid betaine metabolic process | GO:0006577 | 7 | 0.309 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.305 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.293 | |
| cation transport | GO:0006812 | 399 | 0.292 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.290 | |
| intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1990127 | 1 | 0.288 | |
| chloride transport | GO:0006821 | 32 | 0.285 | |
| locomotory behavior | GO:0007626 | 195 | 0.271 | |
| cation homeostasis | GO:0055080 | 212 | 0.267 | |
| negative regulation of peptidyl serine phosphorylation | GO:0033137 | 10 | 0.267 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.263 | |
| endocrine process | GO:0050886 | 39 | 0.260 | |
| drinking behavior | GO:0042756 | 5 | 0.260 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.254 | |
| regulation of defense response | GO:0031347 | 233 | 0.253 | |
| forebrain development | GO:0030900 | 302 | 0.252 | |
| regulation of protein transport | GO:0051223 | 163 | 0.250 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.244 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.241 | |
| amino acid transport | GO:0006865 | 61 | 0.239 | |
| l amino acid transport | GO:0015807 | 32 | 0.239 | |
| regulation of neurotrophin trk receptor signaling pathway | GO:0051386 | 4 | 0.232 | |
| cellular response to peptide | GO:1901653 | 92 | 0.232 | |
| amine metabolic process | GO:0009308 | 45 | 0.231 | |
| negative regulation of smooth muscle cell apoptotic process | GO:0034392 | 1 | 0.229 | |
| cell growth involved in cardiac muscle cell development | GO:0061049 | 3 | 0.228 | |
| regulation of transforming growth factor beta secretion | GO:2001201 | 1 | 0.223 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.222 | |
| camera type eye photoreceptor cell differentiation | GO:0060219 | 15 | 0.222 | |
| urea transport | GO:0015840 | 4 | 0.220 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.220 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.219 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.216 | |
| eye photoreceptor cell differentiation | GO:0001754 | 41 | 0.214 | |
| multicellular organism growth | GO:0035264 | 161 | 0.213 | |
| ovulation | GO:0030728 | 15 | 0.213 | |
| regulation of blood volume by renin angiotensin | GO:0002016 | 7 | 0.212 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.210 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.209 | |
| regulation of protein tyrosine kinase activity | GO:0061097 | 17 | 0.208 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.203 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.199 | |
| fat soluble vitamin catabolic process | GO:0042363 | 1 | 0.196 | |
| limb development | GO:0060173 | 166 | 0.195 | |
| angiotensin activated signaling pathway | GO:0038166 | 4 | 0.192 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.190 | |
| proton transport | GO:0015992 | 35 | 0.183 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.179 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.179 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.179 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.176 | |
| physiological cardiac muscle hypertrophy | GO:0003301 | 3 | 0.176 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.171 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.165 | |
| transforming growth factor beta secretion | GO:0038044 | 1 | 0.163 | |
| regulation of protein localization | GO:0032880 | 231 | 0.162 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.162 | |
| bile acid and bile salt transport | GO:0015721 | 5 | 0.162 | |
| carnitine metabolic process | GO:0009437 | 7 | 0.158 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.154 | |
| regulation of renal sodium excretion | GO:0035813 | 3 | 0.153 | |
| excretion | GO:0007588 | 22 | 0.152 | |
| renal system development | GO:0072001 | 225 | 0.152 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.150 | |
| histamine transport | GO:0051608 | 2 | 0.149 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.148 | |
| hydrogen transport | GO:0006818 | 35 | 0.148 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.147 | |
| positive regulation of metanephric glomerulus development | GO:0072300 | 4 | 0.144 | |
| regulation of blood volume by renal aldosterone | GO:0002017 | 1 | 0.144 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.143 | |
| renal sodium excretion | GO:0035812 | 3 | 0.143 | |
| vasoconstriction | GO:0042310 | 27 | 0.141 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.141 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.140 | |
| cytokine production | GO:0001816 | 319 | 0.137 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.135 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.134 | |
| positive regulation of mesonephros development | GO:0061213 | 20 | 0.134 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.134 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.133 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.131 | |
| response to starvation | GO:0042594 | 65 | 0.130 | |
| regulation of branching involved in ureteric bud morphogenesis | GO:0090189 | 22 | 0.130 | |
| negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress | GO:1902219 | 1 | 0.130 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.129 | |
| cellular response to fructose stimulus | GO:0071332 | 2 | 0.124 | |
| negative regulation of neurotrophin trk receptor signaling pathway | GO:0051387 | 2 | 0.122 | |
| norepinephrine transport | GO:0015874 | 2 | 0.121 | |
| nephron epithelium development | GO:0072009 | 92 | 0.121 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.118 | |
| response to vitamin d | GO:0033280 | 3 | 0.117 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.117 | |
| response to drug | GO:0042493 | 75 | 0.115 | |
| response to corticosterone | GO:0051412 | 1 | 0.114 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.114 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.113 | |
| kidney epithelium development | GO:0072073 | 121 | 0.113 | |
| dehydroascorbic acid transport | GO:0070837 | 3 | 0.112 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.112 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.111 | |
| response to acid chemical | GO:0001101 | 111 | 0.111 | |
| intrinsic apoptotic signaling pathway in response to osmotic stress | GO:0008627 | 2 | 0.110 | |
| renal sodium ion transport | GO:0003096 | 2 | 0.108 | |
| response to nutrient levels | GO:0031667 | 109 | 0.108 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.108 | |
| epithelial cell development | GO:0002064 | 159 | 0.108 | |
| potassium ion transmembrane transport | GO:0071805 | 43 | 0.107 | |
| gonad development | GO:0008406 | 141 | 0.107 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.107 | |
| phospholipase c activating angiotensin activated signaling pathway | GO:0086097 | 1 | 0.104 | |
| negative regulation of ion transport | GO:0043271 | 28 | 0.104 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.103 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.103 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.103 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.102 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.101 | |
| brown fat cell differentiation | GO:0050873 | 36 | 0.099 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.099 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.098 | |
| regulation of phospholipase c activity | GO:1900274 | 3 | 0.098 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.098 | |
| cellular response to osmotic stress | GO:0071470 | 7 | 0.098 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.097 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.097 | |
| organic acid transport | GO:0015849 | 101 | 0.097 | |
| inflammatory response | GO:0006954 | 244 | 0.096 | |
| neuropeptide signaling pathway | GO:0007218 | 19 | 0.095 | |
| angiogenesis | GO:0001525 | 201 | 0.094 | |
| positive regulation of blood pressure | GO:0045777 | 21 | 0.093 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.091 | |
| spermatogenesis | GO:0007283 | 284 | 0.090 | |
| jak stat cascade | GO:0007259 | 42 | 0.090 | |
| response to activity | GO:0014823 | 13 | 0.090 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.090 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.090 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.088 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.088 | |
| potassium ion homeostasis | GO:0055075 | 4 | 0.087 | |
| gland development | GO:0048732 | 330 | 0.087 | |
| male sex differentiation | GO:0046661 | 109 | 0.086 | |
| cellular response to lipid | GO:0071396 | 145 | 0.086 | |
| protein processing | GO:0016485 | 163 | 0.086 | |
| camp metabolic process | GO:0046058 | 40 | 0.086 | |
| regulation of tube size | GO:0035150 | 57 | 0.086 | |
| blood circulation | GO:0008015 | 195 | 0.084 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.083 | |
| nitric oxide biosynthetic process | GO:0006809 | 25 | 0.081 | |
| cognition | GO:0050890 | 149 | 0.081 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.080 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.079 | |
| negative regulation of blood pressure | GO:0045776 | 22 | 0.079 | |
| peptide transport | GO:0015833 | 133 | 0.079 | |
| regulation of transmission of nerve impulse | GO:0051969 | 1 | 0.079 | |
| camera type eye development | GO:0043010 | 266 | 0.077 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.076 | |
| negative regulation of heart rate | GO:0010459 | 4 | 0.075 | |
| peptide hormone processing | GO:0016486 | 9 | 0.075 | |
| positive regulation of phospholipase activity | GO:0010518 | 3 | 0.075 | |
| pallium development | GO:0021543 | 120 | 0.074 | |
| gliogenesis | GO:0042063 | 141 | 0.074 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.074 | |
| nik nf kappab signaling | GO:0038061 | 14 | 0.073 | |
| regulation of cholesterol esterification | GO:0010872 | 2 | 0.073 | |
| response to water deprivation | GO:0009414 | 1 | 0.073 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.073 | |
| oxidation reduction process | GO:0055114 | 342 | 0.072 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 39 | 0.072 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.071 | |
| positive regulation of growth | GO:0045927 | 104 | 0.069 | |
| regulation of intrinsic apoptotic signaling pathway in response to osmotic stress | GO:1902218 | 1 | 0.069 | |
| protein maturation | GO:0051604 | 176 | 0.068 | |
| neurotransmitter uptake | GO:0001504 | 14 | 0.068 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.067 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.067 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.067 | |
| hippocampus development | GO:0021766 | 52 | 0.067 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.067 | |
| regulation of glomerulus development | GO:0090192 | 6 | 0.066 | |
| vitamin d catabolic process | GO:0042369 | 1 | 0.066 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.066 | |
| insulin receptor signaling pathway | GO:0008286 | 49 | 0.065 | |
| hindbrain development | GO:0030902 | 128 | 0.065 | |
| vitamin metabolic process | GO:0006766 | 23 | 0.063 | |
| wnt signaling pathway involved in somitogenesis | GO:0090244 | 4 | 0.062 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.062 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.062 | |
| heart process | GO:0003015 | 94 | 0.062 | |
| heart contraction | GO:0060047 | 93 | 0.062 | |
| response to inorganic substance | GO:0010035 | 96 | 0.061 | |
| cellular homeostasis | GO:0019725 | 240 | 0.061 | |
| negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1902239 | 1 | 0.061 | |
| negative regulation of wnt signaling pathway involved in heart development | GO:0003308 | 4 | 0.061 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.060 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.060 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.059 | |
| ovulation cycle | GO:0042698 | 59 | 0.059 | |
| one carbon compound transport | GO:0019755 | 5 | 0.058 | |
| neurological system process involved in regulation of systemic arterial blood pressure | GO:0001976 | 18 | 0.058 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.058 | |
| response to monosaccharide | GO:0034284 | 67 | 0.058 | |
| epidermis development | GO:0008544 | 187 | 0.057 | |
| cellular response to monosaccharide stimulus | GO:0071326 | 47 | 0.057 | |
| histamine induced gastric acid secretion | GO:0001697 | 1 | 0.057 | |
| mesonephros development | GO:0001823 | 97 | 0.057 | |
| kidney development | GO:0001822 | 213 | 0.057 | |
| response to growth factor | GO:0070848 | 198 | 0.056 | |
| regulation of thyroid hormone generation | GO:2000609 | 4 | 0.056 | |
| cell proliferation in hindbrain | GO:0021534 | 10 | 0.056 | |
| lateral line system development | GO:0048925 | 1 | 0.055 | |
| renal system process involved in regulation of blood volume | GO:0001977 | 4 | 0.054 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.053 | |
| midgut development | GO:0007494 | 4 | 0.053 | |
| regulation of insulin receptor signaling pathway | GO:0046626 | 21 | 0.052 | |
| fat cell differentiation | GO:0045444 | 160 | 0.052 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.051 | |
| hormone metabolic process | GO:0042445 | 86 | 0.051 | |
| positive regulation of inositol phosphate biosynthetic process | GO:0060732 | 2 | 0.051 | |
| regulation of muscle adaptation | GO:0043502 | 31 | 0.051 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.050 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.050 | |
| establishment of blood nerve barrier | GO:0008065 | 3 | 0.050 | |
| female gamete generation | GO:0007292 | 74 | 0.049 | |
| muscle contraction | GO:0006936 | 101 | 0.049 | |
| rhombomere 5 development | GO:0021571 | 4 | 0.049 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.049 | |
| positive regulation of vasoconstriction | GO:0045907 | 4 | 0.049 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.049 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.049 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.049 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.048 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.048 | |
| regulation of kidney development | GO:0090183 | 40 | 0.048 | |
| negative regulation of growth | GO:0045926 | 99 | 0.047 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.046 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.046 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.046 | |
| negative regulation of lipid metabolic process | GO:0045833 | 30 | 0.046 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.046 | |
| muscle tissue development | GO:0060537 | 308 | 0.046 | |
| regulation of cytokine secretion | GO:0050707 | 61 | 0.045 | |
| vasodilation by angiotensin involved in regulation of systemic arterial blood pressure | GO:0002033 | 2 | 0.045 | |
| monoamine transport | GO:0015844 | 33 | 0.045 | |
| photoreceptor cell differentiation | GO:0046530 | 52 | 0.045 | |
| erbb signaling pathway | GO:0038127 | 32 | 0.045 | |
| regulation of intracellular ph | GO:0051453 | 11 | 0.045 | |
| positive regulation of fibroblast proliferation | GO:0048146 | 20 | 0.044 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.044 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.043 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.043 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.043 | |
| adenylate cyclase activating g protein coupled receptor signaling pathway | GO:0007189 | 30 | 0.042 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.042 | |
| regulation of activation of janus kinase activity | GO:0010533 | 1 | 0.042 | |
| positive regulation of nitric oxide biosynthetic process | GO:0045429 | 14 | 0.042 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.042 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.041 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.041 | |
| regulation of angiotensin metabolic process | GO:0060177 | 4 | 0.041 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.041 | |
| response to oxidative stress | GO:0006979 | 123 | 0.041 | |
| regulation of protein kinase c activity | GO:1900019 | 1 | 0.041 | |
| maintenance of location | GO:0051235 | 89 | 0.040 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.040 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.040 | |
| mammary gland duct morphogenesis | GO:0060603 | 38 | 0.039 | |
| protein secretion | GO:0009306 | 111 | 0.039 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.039 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.039 | |
| regulation of norepinephrine secretion | GO:0014061 | 2 | 0.039 | |
| germ cell development | GO:0007281 | 185 | 0.039 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.039 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.039 | |
| regulation of cellular ph | GO:0030641 | 12 | 0.038 | |
| purine ribonucleoside biosynthetic process | GO:0046129 | 19 | 0.038 | |
| dicarboxylic acid transport | GO:0006835 | 29 | 0.038 | |
| tissue migration | GO:0090130 | 68 | 0.038 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.038 | |
| c21 steroid hormone metabolic process | GO:0008207 | 7 | 0.038 | |
| cellular response to starvation | GO:0009267 | 57 | 0.038 | |
| cellular response to hexose stimulus | GO:0071331 | 47 | 0.038 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.038 | |
| retinal cell programmed cell death | GO:0046666 | 8 | 0.038 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.038 | |
| glomerulus development | GO:0032835 | 40 | 0.038 | |
| cochlear nucleus development | GO:0021747 | 4 | 0.038 | |
| planar cell polarity pathway involved in outflow tract morphogenesis | GO:0061347 | 2 | 0.037 | |
| renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure | GO:0003072 | 5 | 0.037 | |
| c21 steroid hormone biosynthetic process | GO:0006700 | 3 | 0.037 | |
| response to insulin | GO:0032868 | 100 | 0.037 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.037 | |
| positive regulation of camp mediated signaling | GO:0043950 | 3 | 0.037 | |
| positive regulation of renal sodium excretion | GO:0035815 | 2 | 0.036 | |
| striated muscle contraction | GO:0006941 | 45 | 0.036 | |
| skin development | GO:0043588 | 220 | 0.036 | |
| positive regulation of insulin receptor signaling pathway | GO:0046628 | 4 | 0.036 | |
| male gamete generation | GO:0048232 | 285 | 0.035 | |
| disruption of cells of other organism involved in symbiotic interaction | GO:0051818 | 13 | 0.035 | |
| cell growth | GO:0016049 | 130 | 0.035 | |
| sulfur compound transport | GO:0072348 | 9 | 0.035 | |
| response to water | GO:0009415 | 1 | 0.035 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.035 | |
| forebrain neuron development | GO:0021884 | 30 | 0.035 | |
| regulation of microvillus organization | GO:0032530 | 3 | 0.035 | |
| glucose metabolic process | GO:0006006 | 92 | 0.035 | |
| regulation of protein processing | GO:0070613 | 96 | 0.035 | |
| cardiac right atrium morphogenesis | GO:0003213 | 3 | 0.035 | |
| fat soluble vitamin metabolic process | GO:0006775 | 11 | 0.035 | |
| cellular response to steroid hormone stimulus | GO:0071383 | 33 | 0.035 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.034 | |
| response to alcohol | GO:0097305 | 48 | 0.034 | |
| telencephalon development | GO:0021537 | 186 | 0.034 | |
| positive regulation of branching involved in ureteric bud morphogenesis | GO:0090190 | 18 | 0.034 | |
| retina vasculature development in camera type eye | GO:0061298 | 17 | 0.034 | |
| peptide secretion | GO:0002790 | 114 | 0.034 | |
| hormone mediated signaling pathway | GO:0009755 | 23 | 0.034 | |
| ovulation from ovarian follicle | GO:0001542 | 9 | 0.034 | |
| vasodilation by norepinephrine epinephrine involved in regulation of systemic arterial blood pressure | GO:0002025 | 3 | 0.034 | |
| cerebellar granule cell precursor proliferation | GO:0021930 | 10 | 0.034 | |
| canonical wnt signaling pathway involved in regulation of cell proliferation | GO:0044340 | 3 | 0.033 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.033 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.033 | |
| fertilization | GO:0009566 | 127 | 0.033 | |
| positive regulation of protein secretion | GO:0050714 | 52 | 0.033 | |
| regulation of long term neuronal synaptic plasticity | GO:0048169 | 19 | 0.033 | |
| axis elongation | GO:0003401 | 30 | 0.033 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.033 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.032 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.032 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.032 | |
| metencephalon development | GO:0022037 | 89 | 0.032 | |
| phosphatidylinositol mediated signaling | GO:0048015 | 41 | 0.032 | |
| regulation of superoxide anion generation | GO:0032928 | 4 | 0.032 | |
| regulation of secretion | GO:0051046 | 274 | 0.032 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.032 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.031 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.031 | |
| regulation of glycogen metabolic process | GO:0070873 | 13 | 0.031 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.031 | |
| sodium ion transmembrane transport | GO:0035725 | 49 | 0.031 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.031 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.031 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.031 | |
| negative regulation of cellular carbohydrate metabolic process | GO:0010677 | 19 | 0.031 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.031 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.030 | |
| limb morphogenesis | GO:0035108 | 149 | 0.030 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.030 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.030 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.030 | |
| digestive tract development | GO:0048565 | 190 | 0.030 | |
| positive regulation of phospholipase c activity | GO:0010863 | 2 | 0.030 | |
| energy reserve metabolic process | GO:0006112 | 39 | 0.030 | |
| digestion | GO:0007586 | 40 | 0.030 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.030 | |
| interleukin 10 secretion | GO:0072608 | 4 | 0.030 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.030 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.030 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.030 | |
| l glutamate transport | GO:0015813 | 16 | 0.030 | |
| renal response to blood flow involved in circulatory renin angiotensin regulation of systemic arterial blood pressure | GO:0001999 | 6 | 0.030 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.029 | |
| positive regulation of extracellular matrix organization | GO:1903055 | 4 | 0.029 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.029 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.029 | |
| retina vasculature morphogenesis in camera type eye | GO:0061299 | 10 | 0.029 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.029 | |
| activation of phospholipase c activity | GO:0007202 | 2 | 0.029 | |
| ventricular cardiac muscle cell action potential | GO:0086005 | 4 | 0.028 | |
| protein localization to organelle | GO:0033365 | 185 | 0.028 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.028 | |
| regulation of kidney size | GO:0035564 | 3 | 0.028 | |
| regulation of neuron death | GO:1901214 | 134 | 0.028 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.028 | |
| negative regulation of sterol transport | GO:0032372 | 4 | 0.028 | |
| cell cell adhesion | GO:0098609 | 41 | 0.028 | |
| positive regulation of blood circulation | GO:1903524 | 22 | 0.028 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.028 | |
| synaptic transmission | GO:0007268 | 329 | 0.028 | |
| physiological muscle hypertrophy | GO:0003298 | 3 | 0.028 | |
| regulation of cell motility | GO:2000145 | 236 | 0.028 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.027 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.027 | |
| mineralocorticoid biosynthetic process | GO:0006705 | 1 | 0.027 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.027 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.027 | |
| positive regulation of cytokine secretion | GO:0050715 | 41 | 0.027 | |
| regulation of neurotransmitter levels | GO:0001505 | 87 | 0.027 | |
| sterol metabolic process | GO:0016125 | 58 | 0.026 | |
| drug catabolic process | GO:0042737 | 2 | 0.026 | |
| drug metabolic process | GO:0017144 | 4 | 0.026 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.026 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.026 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.026 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.026 | |
| cellular potassium ion transport | GO:0071804 | 43 | 0.026 | |
| regulation of inositol phosphate biosynthetic process | GO:0010919 | 3 | 0.026 | |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.026 | |
| hepatic duct development | GO:0061011 | 1 | 0.026 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.026 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.026 | |
| learning or memory | GO:0007611 | 148 | 0.026 | |
| norepinephrine secretion | GO:0048243 | 2 | 0.026 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.026 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.026 | |
| sperm capacitation | GO:0048240 | 17 | 0.025 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.025 | |
| regulation of inward rectifier potassium channel activity | GO:1901979 | 1 | 0.025 | |
| potassium ion import | GO:0010107 | 1 | 0.025 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.025 | |
| lipid transport | GO:0006869 | 98 | 0.025 | |
| cellular response to prostaglandin stimulus | GO:0071379 | 2 | 0.025 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.025 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.025 | |
| planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:0061349 | 2 | 0.025 | |
| negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis | GO:2000149 | 1 | 0.025 | |
